Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension

被引：0
|
作者：
van der Heijde, Desiree [1 ]
Deodhar, Atul [2 ]
Maksymowych, Walter [3 ]
Sieper, Joachim [4 ,5 ,6 ]
Van den Bosch, Filip [7 ]
Kim, Tae-Hwan [8 ]
Kishimoto, Mitsumasa [9 ]
Ostor, Andrew [10 ,11 ]
Combe, Bernard [12 ]
Sui, Yunxia [13 ]
Duan, Yuanyuan [14 ]
Chu, Alvina D. [14 ]
Song, In-Ho [14 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Meerssen, Netherlands
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Univ Alberta, Dept Med, Edmonton, AB, Canada
[4] Charite Univ Med Berlin, Dept Gastroenterol Infectiol & Rheumatol Includin, Berlin, Germany
[5] Free Univ Berlin, Berlin, Germany
[6] Humboldt Univ, Berlin, Germany
[7] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium
[8] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea
[9] Kyorin Univ, Sch Med, Dept Nephrol & Rheumatol, Tokyo, Japan
[10] Monash Univ, Cabrini Hosp, Malvern, Australia
[11] Emertius Res, Malvern, Australia
[12] Montpellier Univ, Montpellier, France
[13] AbbVie, N Chicago, IL 60064 USA
[14] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0924
引用
收藏
页码：1925 / 1928
页数：4
相关论文
共 50 条
  • [21] Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Baraliakos, Xenofon
    Deodhar, Atul
    Dougados, Maxime
    Gensler, Lianne S.
    Molto, Anna
    Ramiro, Sofia
    Kivitz, Alan J.
    Poddubnyy, Denis
    Oortgiesen, Marga
    Vaux, Thomas
    Fleurinck, Carmen
    Shepherd-Smith, Julie
    de la Loge, Christine
    de Peyrecave, Natasha
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1943 - 1958
  • [22] Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
    van der Heijde, Desiree
    Baraliakos, Xenofon
    Sieper, Joachim
    Deodhar, Atul
    Inman, Robert D.
    Kameda, Hideto
    Zeng, Xiaofeng
    Sui, Yunxia
    Bu, Xianwei
    Pangan, Aileen L.
    Wung, Peter
    Song, In-Ho
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : 1515 - 1523
  • [23] Efficacy and Tolerability of Elamipretide in Patients With Barth Syndrome: Results From Tazpower, a Randomized, Double-Blind, Placebo-Controlled, Crossover and Open-Label Extension Trial
    Vernon, Hilary J.
    Thompson, WIlliam R.
    Aiudi, Anthony
    Jones, John J.
    Carr, Jim
    Hornby, Brittany DeCroes
    CIRCULATION, 2019, 140
  • [24] Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
    Bao, Chunde
    Huang, Feng
    Khan, Muhammad Asim
    Fei, Kaiyin
    Wu, Zhong
    Han, Chenglong
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 (09) : 1654 - 1663
  • [25] Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study
    Takashi Wada
    Masaya Inagaki
    Toru Yoshinari
    Ryuji Terata
    Naoko Totsuka
    Miki Gotou
    Gaia Hashimoto
    Clinical and Experimental Nephrology, 2021, 25 : 120 - 130
  • [26] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Lesley M. Arnold
    Kenneth N. Schikler
    Lucinda Bateman
    Tahira Khan
    Lynne Pauer
    Pritha Bhadra-Brown
    Andrew Clair
    Marci L. Chew
    Joseph Scavone
    Pediatric Rheumatology, 14
  • [27] SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF UPPER FACIAL LINES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH OPEN-LABEL EXTENSION
    Trevidic, Patrick
    Connolly, Simon A.
    Biwer, Bernard
    Weissenberger, Petra
    Kestemont, Philippe
    Noah, Ernst M.
    Sattler, Gerhard
    Kerscher, Martina
    TOXICON, 2018, 156 : S110 - S110
  • [28] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Arnold, Lesley M.
    Schikler, Kenneth N.
    Bateman, Lucinda
    Khan, Tahira
    Pauer, Lynne
    Bhadra-Brown, Pritha
    Clair, Andrew
    Chew, Marci L.
    Scavone, Joseph
    PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [29] Topiramate in migraine prophylaxis: An open-label extension of a double-blind, placebo-controlled study
    Hart, DE
    Calder, CS
    Storey, JR
    Riback, P
    Potter, DL
    Wymer, JP
    Beesley, BA
    NEUROLOGY, 2002, 58 (07) : A496 - A497
  • [30] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
    Xenofon Baraliakos
    Désirée van der Heijde
    Joachim Sieper
    Robert D. Inman
    Hideto Kameda
    Yihan Li
    Xianwei Bu
    Anna Shmagel
    Peter Wung
    In-Ho Song
    Atul Deodhar
    Arthritis Research & Therapy, 25
12345